Approval · Notice of Compliance 3301 · 1997
ZITHROMAX: Notice of Compliance 3301
Issued November 17, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3301
- Date
- November 17, 1997
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for treatment in pediatric patients of community acquired pneumonia due to chlamydia pneumoniae haemophilus influenzae, mycoplasma pneumoniae or streptococcus pneumoniae
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZITHROMAX | Not yet assigned | — |
Medicinal ingredients
- AZITHROMYCIN 100 MG per 5ML
- AZITHROMYCIN 200 MG per 5ML